Keyword: diabetes drugs

News

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

07.06.2013 - In a leafy suburb of Frankfurt, a state-of-the-art plant churns out up to 1 million insulin pens every day in French drugmaker Sanofi's drive to keep its no. 2 spot in the $43...

News

Eli Lilly Broadens Diabetes Offer

03.05.2013 - Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market. The global...

News

AstraZeneca Buys Equal Say over Amylin Drugs

10.08.2012 - AstraZeneca has opted to pay a further $135 million to Bristol-Myers Squibb to get an equal say in decision-making regarding drugs developed by Amylin Pharmaceuticals, the diabetes...

News

Novo Nordisk Raises Targets on Victoza, Insulin Demand

09.08.2012 - Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations...

News

AstraZeneca Hungry to Refill Medicine Cabinet

30.06.2012 - Simon Lowth may only be the interim chief executive of AstraZeneca but he is ready to sign off on bold deals. The decision to pair up with Bristol-Myers Squibb to buy diabetes...

News

Novo Nordisk Hit by U.S. Delay to New Insulin Drug

08.06.2012 - Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...

News

Bristol, AstraZeneca among Amylin Bidders

02.06.2012 - AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...

News

Sanofi Aims to Expand in Diabetes Market

01.06.2012 - Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...